
Biomedicines, Год журнала: 2024, Номер 12(11), С. 2637 - 2637
Опубликована: Ноя. 19, 2024
Treatment-resistant schizophrenia (TRS) may be considered as a neuro-immune disorder. Electroconvulsive therapy (ECT) remains an important therapeutic option for patients with TRS, however, its impact on cytokine profile is barely investigated. Therefore, this study attempts to establish associations between serum cytokines IL-6, IL-12, IL-5, IL-10 and TGF-β1 changes (pre- post-ECT) the effectiveness of ECT in TRS patients. The second aim search correlations concentrations above specified psychometric assessments clinical symptoms.
Язык: Английский